These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12140215)

  • 1. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Fielder AR; Stephens DA; Moseley MJ
    Br J Ophthalmol; 2002 Aug; 86(8):915-9. PubMed ID: 12140215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Moseley MJ; Stephens DA; Fielder AR
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3048-54. PubMed ID: 15326120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amblyopia treatment on stereoacuity.
    Stewart CE; Wallace MP; Stephens DA; Fielder AR; Moseley MJ;
    J AAPOS; 2013 Apr; 17(2):166-73. PubMed ID: 23622448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years.
    Simonsz-Tóth B; Joosse MV; Besch D
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):379-389. PubMed ID: 30397791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia.
    Agervi P; Kugelberg U; Kugelberg M; Simonsson G; Fornander M; Zetterström C
    Ophthalmology; 2010 Feb; 117(2):381-7. PubMed ID: 20006908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of unilateral amblyopia: factors influencing visual outcome.
    Stewart CE; Fielder AR; Stephens DA; Moseley MJ
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3152-60. PubMed ID: 16123414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling dose-response in amblyopia: toward a child-specific treatment plan.
    Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2589-94. PubMed ID: 17525188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for unilateral and bilateral refractive amblyopia.
    Taylor K; Powell C; Hatt SR; Stewart C
    Cochrane Database Syst Rev; 2012 Apr; (4):CD005137. PubMed ID: 22513928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for unilateral refractive amblyopia.
    Shotton K; Powell C; Voros G; Hatt SR
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005137. PubMed ID: 18843683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objectively monitored patching regimens for treatment of amblyopia: randomised trial.
    Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
    BMJ; 2007 Oct; 335(7622):707. PubMed ID: 17855283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.
    Tailor V; Ludden S; Bossi M; Bunce C; Greenwood JA; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD011347. PubMed ID: 35129211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?
    Cleary M
    Br J Ophthalmol; 2000 Jun; 84(6):572-8. PubMed ID: 10837378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with occlusion therapy for childhood amblyopia.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR; ;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6158-66. PubMed ID: 23882695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate spatial frequency letter contrast sensitivity: its relation to visual resolution before and during amblyopia treatment.
    Moseley MJ; Stewart CE; Fielder AR; Stephens DA;
    Ophthalmic Physiol Opt; 2006 Jan; 26(1):1-4. PubMed ID: 16390475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcomes after spectacles treatment in children with bilateral high refractive amblyopia.
    Lin PW; Chang HW; Lai IC; Teng MC
    Clin Exp Optom; 2016 Nov; 99(6):550-554. PubMed ID: 27426739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Adherence to Glasses Wearing During Amblyopia Treatment and Improvement in Visual Acuity.
    Maconachie GD; Farooq S; Bush G; Kempton J; Proudlock FA; Gottlob I
    JAMA Ophthalmol; 2016 Dec; 134(12):1347-1353. PubMed ID: 27737444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractive adaptation in amblyopia: quantification of effect and implications for practice.
    Stewart CE; Moseley MJ; Fielder AR; Stephens DA;
    Br J Ophthalmol; 2004 Dec; 88(12):1552-6. PubMed ID: 15548811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study.
    Moseley MJ; Fielder AR; Irwin M; Jones HS; Auld RJ
    Br J Ophthalmol; 1997 Nov; 81(11):956-61. PubMed ID: 9505818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical treatment of amblyopia in older children and adults is essential prior to enrolment in a clinical trial.
    Gao TY; Anstice N; Babu RJ; Black JM; Bobier WR; Dai S; Guo CX; Hess RF; Jenkins M; Jiang Y; Kearns L; Kowal L; Lam CSY; Pang PCK; Parag V; South J; Staffieri SE; Wadham A; Walker N; Thompson B;
    Ophthalmic Physiol Opt; 2018 Mar; 38(2):129-143. PubMed ID: 29356022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial.
    Moseley MJ; Wallace MP; Stephens DA; Fielder AR; Smith LC; Stewart CE;
    Trials; 2015 Apr; 16():189. PubMed ID: 25906974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.